NASA licenses its bioreactor to biotech firm for $400,000 and royalties
NASA has licensed the "bioreactor" it developed to simulate cell growth in space to a Maryland biotechnology firm that hopes to use the space agency technology in developing four different commercial products, including a "liver assist device" that may one day do for the victims of liver failure...
Subscription Required
This content requires a subscription to one of the Aviation Week Intelligence Network (AWIN) bundles.
Schedule a demo today to find out how you can access this content and similar content related to your area of the global aviation industry.
Already an AWIN subscriber? Login
Did you know? Aviation Week has won top honors multiple times in the Jesse H. Neal National Business Journalism Awards, the business-to-business media equivalent of the Pulitzer Prizes.
Related Content
